Markers of Inflammation and Bone Turnover in Type 2 Diabetic Patients at Risk of Charcot Arthropathy.

IF 0.5 4区医学 Q4 ORTHOPEDICS

Journal of the American Podiatric Medical Association Pub Date : 2025-03-13 DOI:10.7547/24-116

Salini Dharmadas, Harish Kumar, Minnie Pillay, Thacho Sukumaran Mangalanandan, Lakshmanan Vivek, Valiyaparambil Pavithran Praveen, Arun Bal

{"title":"Markers of Inflammation and Bone Turnover in Type 2 Diabetic Patients at Risk of Charcot Arthropathy.","authors":"Salini Dharmadas, Harish Kumar, Minnie Pillay, Thacho Sukumaran Mangalanandan, Lakshmanan Vivek, Valiyaparambil Pavithran Praveen, Arun Bal","doi":"10.7547/24-116","DOIUrl":null,"url":null,"abstract":"Background: Recent research indicates that inflammation-induced changes in the RANKL/RANK/OPG pathway play a significant role in the development of Charcot arthropathy. Considering the severe implications of Charcot arthropathy, cost-effective screening of patients at risk of the disease could prove to be an effective preventative strategy. As an initial endeavour in our attempt to identify a predictive biomarker for Charcot arthropathy, we conducted an analysis of inflammation and bone turnover markers in diabetic patients at risk of Charcot arthropathy. We then compared these markers with those of patients in the acute stage of Charcot arthropathy and healthy controls.Methods: In this cross-sectional study, 45 subjects were carefully selected and categorized into three groups, with 15 individuals in each group. Group 1 encompassed patients over 50 years of age, with more than 10 years of type 2 diabetes and severe neuropathy (DN). Group 2 consisted of patients diagnosed with acute-stage Charcot arthropathy (aCA), while Group 3 consisted of healthy, non-diabetic, age-matched controls (N). Serum inflammatory markers and bone turnover markers were analyzed across these groups.Results: Significant differences were only noted in the median values of HbA1c (P=0.000), VPT (P=0.000), and OPG (P=0.009) among the groups under study. No notable increase was observed in the serum levels of the inflammatory marker IL6 (P value - 0.071), the bone resorption marker TRAP5B (P value - 0.066), or the bone formation marker BALP (0.251) across the groups. However, a positive correlation was identified between IL-6 and OPG in the aCA group (r=0.900, P=0.001).Conclusion: In alignment with the existing literature, serum OPG levels were found to be elevated in the aCA group compared to the control groups. The observed similarities in serum levels of IL6 and TRAP5B across the groups are noteworthy and warrant further investigation.","PeriodicalId":17241,"journal":{"name":"Journal of the American Podiatric Medical Association","volume":" ","pages":"1-21"},"PeriodicalIF":0.5000,"publicationDate":"2025-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the American Podiatric Medical Association","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.7547/24-116","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ORTHOPEDICS","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Recent research indicates that inflammation-induced changes in the RANKL/RANK/OPG pathway play a significant role in the development of Charcot arthropathy. Considering the severe implications of Charcot arthropathy, cost-effective screening of patients at risk of the disease could prove to be an effective preventative strategy. As an initial endeavour in our attempt to identify a predictive biomarker for Charcot arthropathy, we conducted an analysis of inflammation and bone turnover markers in diabetic patients at risk of Charcot arthropathy. We then compared these markers with those of patients in the acute stage of Charcot arthropathy and healthy controls.

Methods: In this cross-sectional study, 45 subjects were carefully selected and categorized into three groups, with 15 individuals in each group. Group 1 encompassed patients over 50 years of age, with more than 10 years of type 2 diabetes and severe neuropathy (DN). Group 2 consisted of patients diagnosed with acute-stage Charcot arthropathy (aCA), while Group 3 consisted of healthy, non-diabetic, age-matched controls (N). Serum inflammatory markers and bone turnover markers were analyzed across these groups.

Results: Significant differences were only noted in the median values of HbA1c (P=0.000), VPT (P=0.000), and OPG (P=0.009) among the groups under study. No notable increase was observed in the serum levels of the inflammatory marker IL6 (P value - 0.071), the bone resorption marker TRAP5B (P value - 0.066), or the bone formation marker BALP (0.251) across the groups. However, a positive correlation was identified between IL-6 and OPG in the aCA group (r=0.900, P=0.001).

Conclusion: In alignment with the existing literature, serum OPG levels were found to be elevated in the aCA group compared to the control groups. The observed similarities in serum levels of IL6 and TRAP5B across the groups are noteworthy and warrant further investigation.

查看原文本刊更多论文

有患夏科氏关节病风险的 2 型糖尿病患者的炎症和骨质流失标志物

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of the American Podiatric Medical Association 医学-整形外科

CiteScore

1.10

自引率

0.00%

发文量

128

审稿时长

6-12 weeks

期刊介绍： The Journal of the American Podiatric Medical Association, the official journal of the Association, is the oldest and most frequently cited peer-reviewed journal in the profession of foot and ankle medicine. Founded in 1907 and appearing 6 times per year, it publishes research studies, case reports, literature reviews, special communications, clinical correspondence, letters to the editor, book reviews, and various other types of submissions. The Journal is included in major indexing and abstracting services for biomedical literature.